Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
6.17
-0.08 (-1.28%)
Nov 20, 2024, 4:00 PM EST - Market closed
Adverum Biotechnologies Market Cap
Adverum Biotechnologies has a market cap or net worth of $128.35 million as of November 21, 2024. Its market cap has increased by 33.01% in one year.
Market Cap
128.35M
Enterprise Value
48.37M
1-Year Change
33.01%
Ranking
Category
Stock Price
$6.17
Market Cap Chart
Since July 31, 2014, Adverum Biotechnologies's market cap has decreased from $581.50M to $128.35M, a decrease of -77.93%. That is a compound annual growth rate of -13.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 130.00M | 70.83% |
| Dec 29, 2023 | 76.10M | 31.66% |
| Dec 30, 2022 | 57.80M | -66.53% |
| Dec 31, 2021 | 172.70M | -83.66% |
| Dec 31, 2020 | 1.06B | 42.01% |
| Dec 31, 2019 | 744.10M | 275.81% |
| Dec 31, 2018 | 198.00M | 25.63% |
| Dec 29, 2017 | 157.60M | 30.25% |
| Dec 30, 2016 | 121.00M | -50.65% |
| Dec 31, 2015 | 245.20M | -79.79% |
| Dec 31, 2014 | 1.21B | 108.67% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elutia | 135.90M |
| Seer, Inc. | 135.33M |
| Puma Biotechnology | 133.27M |
| Inhibikase Therapeutics | 133.04M |
| Zentek | 132.60M |
| Skye Bioscience | 131.85M |
| Cardiff Oncology | 131.41M |
| Telomir Pharmaceuticals | 130.32M |